|
US5239084A
(en)
|
1990-06-29 |
1993-08-24 |
Hoffmann-La Roche Inc. |
Substituted aminoalkyl biphenyl compounds
|
|
US5827868A
(en)
|
1991-10-07 |
1998-10-27 |
E. R. Squibb & Sons, Inc. |
Prostaglandin analogs
|
|
US5565485A
(en)
|
1993-03-19 |
1996-10-15 |
Merck & Co., Inc. |
Biphenyl compounds useful or endothelin antagonists
|
|
US5334598A
(en)
|
1993-03-19 |
1994-08-02 |
Merck & Co., Inc. |
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
|
|
US5391566A
(en)
|
1993-07-20 |
1995-02-21 |
Merck & Co., Inc. |
Benzimidazolinones substituted with phenoxyphenylacetic acid derivatives
|
|
DE19601782A1
(de)
|
1996-01-19 |
1997-07-24 |
Merck Patent Gmbh |
Chinolin-2-(1H)one
|
|
CO4960662A1
(es)
|
1997-08-28 |
2000-09-25 |
Novartis Ag |
Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
|
|
CA2333554A1
(en)
|
1998-06-17 |
1999-12-23 |
Chu-Baio Xue |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
US6617351B1
(en)
|
1998-07-31 |
2003-09-09 |
Eli Lilly And Company |
Amide, carbamate, and urea derivatives
|
|
CN1183113C
(zh)
|
1999-04-28 |
2005-01-05 |
阿文蒂斯药物德国有限公司 |
作为ppar受体配体的三芳基酸衍生物
|
|
DE19937537A1
(de)
|
1999-08-09 |
2001-03-08 |
Gruenenthal Gmbh |
Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate
|
|
WO2001014882A1
(fr)
|
1999-08-23 |
2001-03-01 |
Bml, Inc. |
Identification des proprietes d'une substance pour les recepteurs de prostaglandine d
|
|
US20010047027A1
(en)
|
2000-04-12 |
2001-11-29 |
Marc Labelle |
Prostaglandin D2 receptor antagonists
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
JP4279561B2
(ja)
|
2001-05-23 |
2009-06-17 |
メルク フロスト カナダ リミテツド |
プロスタグランジンＤ２受容体拮抗薬としてのジヒドロピロロ［１，２−ａ］インドールおよびテトラヒドロピリド［１，２−ａ］−インドール誘導体
|
|
WO2003006670A2
(en)
|
2001-07-09 |
2003-01-23 |
Axys Pharmaceuticals, Inc. |
2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
JP4269052B2
(ja)
*
|
2001-09-14 |
2009-05-27 |
アムジエン・インコーポレーテツド |
連結ビアリール化合物
|
|
NZ539406A
(en)
|
2002-10-30 |
2007-05-31 |
Merck Frosst Canada Ltd |
Pyridopyrrolizine and pyridoindolizine derivatives
|
|
JP2004182657A
(ja)
|
2002-12-04 |
2004-07-02 |
Eisai Co Ltd |
Ｈｄｌレベル上昇促進剤
|
|
EP1585511B1
(en)
*
|
2002-12-20 |
2013-01-23 |
Amgen Inc. |
Asthma and allergic inflammation modulators
|
|
DE60303238T2
(de)
|
2003-04-25 |
2006-09-14 |
Actimis Pharmaceuticals, Inc., La Jolla |
Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
|
|
EP1675826A1
(en)
|
2003-10-14 |
2006-07-05 |
Oxagen Limited |
Compounds having crth2 antagonist activity
|
|
GB0324763D0
(en)
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
|
EP1688138A4
(en)
|
2003-11-26 |
2008-01-16 |
Takeda Pharmaceutical |
AGENT FOR REGULATING THE FUNCTION OF A RECEIVER
|
|
US7019022B2
(en)
|
2003-12-15 |
2006-03-28 |
Merck Frosst Canada & Co. |
Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
|
|
CN1942428A
(zh)
|
2004-04-13 |
2007-04-04 |
默克公司 |
Cetp抑制剂
|
|
GB0409921D0
(en)
|
2004-05-04 |
2004-06-09 |
Novartis Ag |
Organic compounds
|
|
GB0415320D0
(en)
*
|
2004-07-08 |
2004-08-11 |
Astrazeneca Ab |
Novel compounds
|
|
BRPI0515209A
(pt)
|
2004-08-17 |
2008-07-08 |
Galderma Reseach & Dev S N C |
compostos, composição cosmética, usos de uma composição e composição farmacêutica
|
|
EA200700711A1
(ru)
|
2004-09-21 |
2008-02-28 |
Эсерсис, Инк. |
Производные бензимидазолуксусной кислоты, проявляющие антагонизм в отношении рецептора crth2, и их применение
|
|
US7405215B2
(en)
|
2004-09-21 |
2008-07-29 |
Wyeth |
Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
|
|
US20070299122A1
(en)
|
2004-11-08 |
2007-12-27 |
Tobert Jonathan A |
Method of Treating Pathological Blushing
|
|
PE20061124A1
(es)
|
2004-11-23 |
2006-10-13 |
Pfizer Prod Inc |
Compuestos y derivados de dibencil amina
|
|
GB0510584D0
(en)
|
2005-05-24 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
GB0518783D0
(en)
|
2005-09-14 |
2005-10-26 |
Argenta Discovery Ltd |
Indolizine compounds
|
|
EP2407459A1
(en)
|
2005-09-27 |
2012-01-18 |
Shionogi & Co., Ltd. |
Synthetic intermediate in the production of a sulfonamide derivative having PGD2 receptor antagonistic activity
|
|
WO2007039736A1
(en)
|
2005-10-06 |
2007-04-12 |
Astrazeneca Ab |
Novel compounds
|
|
US20080293775A1
(en)
*
|
2005-12-15 |
2008-11-27 |
Astrazeneca Ab |
Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease
|
|
ES2614090T3
(es)
|
2005-12-29 |
2017-05-29 |
Celtaxsys, Inc. |
Derivados de diamina como inhibidores de leucotrieno A4 hidrolasa
|
|
EA201200423A1
(ru)
*
|
2006-06-09 |
2012-08-30 |
Икос Корпорейшн |
Замещенные фенилуксусные кислоты как dp-2-антагонисты
|
|
BRPI0715617A2
(pt)
*
|
2006-08-21 |
2014-06-03 |
Array Biopharma Inc |
Derivados do ácido fenoxifenilacético 4-substituído
|
|
CN101765585B
(zh)
|
2007-06-12 |
2017-03-15 |
尔察祯有限公司 |
抗菌剂
|
|
AU2008270438B2
(en)
|
2007-07-02 |
2013-10-10 |
F. Hoffmann-La Roche Ag |
Imidazole derivatives as CCR2 receptor antagonists
|
|
CN101801952A
(zh)
|
2007-10-01 |
2010-08-11 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr受体拮抗剂的n-杂环联芳基甲酰胺类化合物
|
|
GB0719521D0
(en)
|
2007-10-05 |
2007-11-14 |
Argenta Discovery Ltd |
Compounds
|
|
GB0722203D0
(en)
|
2007-11-13 |
2007-12-19 |
Oxagen Ltd |
Use of CRTH2 antagonist compounds
|
|
GB0722216D0
(en)
|
2007-11-13 |
2007-12-27 |
Oxagen Ltd |
Use of crth2 antagonist compounds
|
|
RU2503672C2
(ru)
|
2008-01-18 |
2014-01-10 |
Оксаген Лимитед |
Соединения, обладающие активностью антагонистов crth2
|
|
US8168678B2
(en)
|
2008-02-01 |
2012-05-01 |
Panmira Pharmaceuticals, Inc. |
N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
|
|
EP2245002A4
(en)
|
2008-02-01 |
2011-08-17 |
Amira Pharmaceuticals Inc |
AMINOALKYLBIPHENYL ANTAGONISTS N, N 'DISUBSTITUTED FROM D2 RECEPTORS OF PROSTAGLANDIN
|
|
US8242145B2
(en)
|
2008-02-14 |
2012-08-14 |
Panmira Pharmaceuticals, Llc |
Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors
|
|
US8426449B2
(en)
*
|
2008-04-02 |
2013-04-23 |
Panmira Pharmaceuticals, Llc |
Aminoalkylphenyl antagonists of prostaglandin D2 receptors
|
|
TWI403319B
(zh)
|
2008-07-03 |
2013-08-01 |
Panmira Pharmaceuticals Llc |
前列腺素ｄ2受體之雜烷基拮抗劑
|
|
WO2010039977A2
(en)
|
2008-10-01 |
2010-04-08 |
Amira Pharmaceuticals, Inc. |
Heteroaryl antagonists of prostaglandin d2 receptors
|
|
US8524748B2
(en)
|
2008-10-08 |
2013-09-03 |
Panmira Pharmaceuticals, Llc |
Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
|
|
WO2010057118A2
(en)
|
2008-11-17 |
2010-05-20 |
Amira Pharmaceuticals, Inc. |
Heterocyclic antagonists of prostaglandin d2 receptors
|
|
US20100173313A1
(en)
|
2009-01-08 |
2010-07-08 |
Amira Pharmaceuticals, Inc. |
Biomarkers of inflammation
|
|
JP2013500978A
(ja)
*
|
2009-07-31 |
2013-01-10 |
パンミラ ファーマシューティカルズ，エルエルシー． |
Ｄｐ２受容体アンタゴニストの眼の医薬組成物
|
|
SG177736A1
(en)
|
2009-07-31 |
2012-02-28 |
Panmira Pharmaceuticals Llc |
Dermal formulations of dp2 receptor antagonists
|